Joost P H Drenth Selected Research

lanreotide (Somatuline)

11/2021	Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis.
6/2021	Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.
1/2019	Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.
11/2018	Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.
1/2017	Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study.
4/2016	Alkaline phosphatase predicts response in polycystic liver disease during somatostatin analogue therapy: a pooled analysis.
5/2015	Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trial.
3/2014	Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease.
4/2012	Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease.
11/2009	Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joost P H Drenth Research Topics

Disease

45	Polycystic liver disease 01/2022 - 04/2004
36	Cysts 01/2022 - 04/2004
25	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2022 - 12/2005
21	Infections 04/2022 - 10/2006
21	Fibrosis (Cirrhosis) 01/2022 - 02/2007
14	Pancreatitis 03/2022 - 01/2005
14	Pain (Aches) 01/2022 - 10/2005
14	Chronic Pancreatitis 09/2015 - 07/2003
13	Autoimmune Hepatitis 04/2022 - 07/2010
12	Abdominal Pain (Pain, Abdominal) 01/2022 - 06/2005
10	Gallstones (Gallstone) 01/2022 - 03/2013
10	Hepatitis C 12/2020 - 03/2010
10	Erythromelalgia (Erythermalgia) 10/2019 - 06/2005
10	Chronic Hepatitis C 01/2017 - 07/2008
9	Polycystic Kidney Diseases (Polycystic Kidney Disease) 06/2021 - 12/2005
7	Neoplasms (Cancer) 01/2021 - 10/2009
7	Non-alcoholic Fatty Liver Disease 12/2020 - 08/2014
6	Liver Diseases (Liver Disease) 01/2022 - 10/2013
6	Inflammation (Inflammations) 10/2018 - 05/2004
6	Fever (Fevers) 12/2014 - 05/2004
5	Hemorrhage 11/2021 - 12/2006
5	Disease Progression 08/2021 - 07/2003
5	Inborn Genetic Diseases (Disease, Hereditary) 01/2019 - 06/2008
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 06/2005
5	Crohn Disease (Crohn's Disease) 03/2013 - 07/2004
4	Cholecystolithiasis 10/2021 - 03/2013
4	Cholelithiasis 10/2021 - 12/2014
4	Channelopathies 01/2021 - 03/2008
4	Polyps 01/2021 - 01/2019
4	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020 - 12/2010
3	Hypercholesterolemia 01/2022 - 02/2016
3	COVID-19 01/2022 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2010
3	Fatty Liver 01/2022 - 01/2019
3	Dyspnea (Shortness of Breath) 01/2020 - 03/2010
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 10/2016
3	Adenocarcinoma 06/2013 - 10/2004
3	Mevalonate Kinase Deficiency 03/2013 - 05/2004
2	Cholangitis 04/2022 - 10/2021
2	Hepatomegaly 01/2022 - 11/2014
2	Angiodysplasia 11/2021 - 11/2017
2	Adenoma (Adenomas) 01/2021 - 02/2006
2	Diabetes Mellitus 01/2020 - 01/2017

Drug/Important Bio-Agent (IBA)

24	1-dodecylpyridoxal (PLD)IBA 01/2022 - 12/2005
14	Pharmaceutical PreparationsIBA 03/2022 - 10/2010
14	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2004
14	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2021 - 11/2009
12	Antiviral Agents (Antivirals)IBA 01/2022 - 03/2010
11	EnzymesIBA 11/2019 - 01/2004
10	lanreotide (Somatuline)FDA Link 11/2021 - 11/2009
10	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 07/2008
8	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2022 - 12/2006
7	Biomarkers (Surrogate Marker)IBA 08/2021 - 10/2009
7	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 12/2006
7	Sodium Channels (Sodium Channel)IBA 11/2014 - 06/2005
6	Transaminases (Aminotransferases)IBA 04/2022 - 02/2016
6	Azathioprine (Imuran)FDA LinkGeneric 01/2020 - 07/2010
6	Alkaline PhosphataseIBA 01/2019 - 12/2010
5	Protein Kinase CIBA 01/2019 - 04/2004
5	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2019 - 12/2010
5	Voltage-Gated Sodium ChannelsIBA 11/2014 - 06/2005
5	InterferonsIBA 01/2012 - 01/2009
4	Immunoglobulin G (IgG)IBA 04/2022 - 06/2020
4	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 06/2009
4	Octreotide (Sandostatin)FDA LinkGeneric 11/2021 - 07/2013
4	SteroidsIBA 01/2020 - 01/2016
4	TrypsinogenIBA 09/2015 - 04/2008
3	Adenosine Triphosphatases (ATPase)IBA 01/2022 - 03/2018
3	AntibodiesIBA 01/2022 - 11/2008
3	Pain-FreeIBA 01/2022 - 10/2021
3	obeticholic acidIBA 01/2020 - 08/2016
3	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2019 - 12/2012
3	Infliximab (Remicade)FDA Link 01/2019 - 03/2013
3	Biosimilar PharmaceuticalsIBA 01/2019 - 11/2016
3	BilirubinIBA 01/2019 - 12/2010
3	CT-P13IBA 01/2019 - 11/2016
3	SofosbuvirIBA 01/2017 - 01/2014
3	SodiumIBA 11/2014 - 03/2008
3	Amantadine (Aman)FDA LinkGeneric 06/2014 - 07/2010
3	Kazal Pancreatic Trypsin InhibitorIBA 08/2009 - 01/2007
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2009 - 12/2005
3	LigandsIBA 06/2009 - 07/2004
3	Immunoglobulin D (IgD)IBA 03/2007 - 05/2004
2	Diclofenac (SR 38)FDA LinkGeneric 03/2022 - 01/2021
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2005
2	AutoantibodiesIBA 01/2022 - 01/2019
2	LipidsIBA 01/2022 - 02/2020
2	Analgesics (Analgesic Drugs)IBA 10/2021 - 01/2019
2	Estrogens (Estrogen)FDA Link 01/2021 - 12/2019
2	AlbuminsIBA 01/2021 - 12/2010
2	CholesterolIBA 01/2021 - 01/2019

Therapy/Procedure

31	Therapeutics 11/2021 - 09/2006
17	Cholecystectomy 01/2022 - 03/2013
7	Sclerotherapy 06/2019 - 08/2008
6	Liver Transplantation 01/2021 - 02/2008
4	Drug Therapy (Chemotherapy) 12/2020 - 10/2010
3	Stents 12/2021 - 10/2019
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2021
2	Critical Care (Surgical Intensive Care) 01/2021 - 07/2003
2	Aftercare (After-Treatment) 01/2020 - 06/2019